"Drug Carriers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers.
| Descriptor ID |
D004337
|
| MeSH Number(s) |
D26.255.260 E02.319.300.380
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Drug Carriers".
Below are MeSH descriptors whose meaning is more specific than "Drug Carriers".
This graph shows the total number of publications written about "Drug Carriers" by people in this website by year, and whether "Drug Carriers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2003 | 0 | 5 | 5 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 3 | 0 | 3 |
| 2007 | 3 | 4 | 7 |
| 2008 | 3 | 0 | 3 |
| 2009 | 0 | 1 | 1 |
| 2010 | 3 | 0 | 3 |
| 2011 | 2 | 1 | 3 |
| 2012 | 5 | 0 | 5 |
| 2013 | 1 | 2 | 3 |
| 2014 | 5 | 1 | 6 |
| 2015 | 1 | 2 | 3 |
| 2016 | 3 | 0 | 3 |
| 2017 | 5 | 3 | 8 |
| 2018 | 6 | 2 | 8 |
| 2019 | 3 | 2 | 5 |
| 2020 | 4 | 2 | 6 |
| 2021 | 1 | 3 | 4 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 3 | 3 |
| 2024 | 1 | 1 | 2 |
| 2025 | 1 | 1 | 2 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Carriers" by people in Profiles.
-
Laser-programmable glycosaminoglycan-based nanocarriers co-deliver hypocrellin B and doxorubicin for spatiotemporal chemo-photothermal therapy of hepatocellular carcinoma. Colloids Surf B Biointerfaces. 2026 Nov; 267:115919.
-
Melt-Extruded Paclitaxel Nanocrystal-Loaded Sutures for Sustained Local Drug Delivery. Pharm Res. 2026 Jul; 43(7):2319-2333.
-
Box-Behnken-designed nanostructured lipid carriers of xanthohumol for enhanced cellular uptake in human lung cancer cell line A549: formulation, optimization, characterization, and cytotoxicity assessment. Med Oncol. 2025 Oct 22; 42(11):525.
-
Comparison of the Cytotoxicity, Internalization and Anti-Cancer Drug Delivery Efficacy of Nature Killer Cell Derived Nanovesicles and Extracellular Vesicles. Int J Nanomedicine. 2025; 20:10683-10700.
-
Method development and validation on RP-HPLC method for estimation of xanthohumol in nanostructured lipid carriers drug delivery systems. J Chromatogr B Analyt Technol Biomed Life Sci. 2025 Feb 01; 1252:124437.
-
Uptake of surface-functionalized thermo-responsive polymeric nanocarriers in corticospinal tract motor neurons. Biochem Biophys Res Commun. 2024 02 12; 696:149503.
-
Methyl-Branched Liposomes as a Depot for Sustained Drug Delivery. Nano Lett. 2023 10 25; 23(20):9250-9256.
-
Redox-active polyphenol nanoparticles deprive endogenous glutathione of electrons for ROS generation and tumor chemodynamic therapy. Acta Biomater. 2023 12; 172:423-440.
-
Folic acid-decorated alginate nanoparticles loaded hydrogel for the oral delivery of diferourylmethane in colorectal cancer. Int J Biol Macromol. 2023 Apr 01; 233:123585.
-
Olive oil and clove oil-based nanoemulsion for topical delivery of terbinafine hydrochloride: in?vitro and ex vivo evaluation. Drug Deliv. 2022 Dec; 29(1):600-612.